Patents Represented by Attorney TechLaw LLP
-
Patent number: 7922906Abstract: A composition including the fermentation supernatant from a fermentation of yeast is intended to be conveniently introduced through the wastewater plumbing system of a private home or other facility into a septic system servicing the home or other facility to substantially accelerate the ability of the bacteria resident in the septic system to substantially digest biologically available organic compounds present in the septic system, and methods of accomplishing the same.Type: GrantFiled: February 9, 2010Date of Patent: April 12, 2011Assignee: Advanced BioCatalytics Corp.Inventors: John W. Baldridge, Carl W. Podella
-
Patent number: 7923553Abstract: Crystalline polymorphous forms of rifaximin (INN) antibiotic named rifaximin ? and rifaximin ?, and a poorly crystalline form named rifaximin ?, useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying carried out under controlled conditions until reaching a settled water content in the end product, are the object of the invention.Type: GrantFiled: May 13, 2008Date of Patent: April 12, 2011Assignee: Alfa Wassermann, S.p.A.Inventors: Giuseppe Claudio Viscomi, Manuela Campana, Dario Braga, Donatella Confortini, Vincenzo Cannata, Paolo Righi, Goffredo Rosini
-
Patent number: 7914984Abstract: Methods, compositions and articles of manufacture involving cationic conjugated conformationally flexible polymers are provided. A method for the synthesis of cationic water-soluble polymers with linkages along the polymer main chain structure which disrupt the ability of the polymers to form extended-rod structures is provided. Such polymers may serve in the fabrication of novel optoelectronic devices and in the development of highly efficient biosensors. The invention further relates to the application of these polymers in assay methods.Type: GrantFiled: November 21, 2006Date of Patent: March 29, 2011Assignee: The Regents of the University of CaliforniaInventors: Guillermo C Bazan, Bin Liu
-
Patent number: 7915275Abstract: The present invention relates to Rifaximin polymorphic forms ?, ? and ?, to their use in medicinal preparations for the oral or topical route and to therapeutic methods using them.Type: GrantFiled: October 17, 2007Date of Patent: March 29, 2011Assignee: Alfa Wassermann, S.p.A.Inventors: Giuseppe C. Viscomi, Manuela Campana, Donatella Confortini, Miriam Barbanti, Fiorella Calanni
-
Patent number: 7910305Abstract: Compositions and methods are provided for screening for compounds that modulate insulin promoter activity. Vectors that express green fluorescent protein under the control of the human insulin promoter are introduced into mouse and human cells in which the insulin promoter is expressed in a glucose-responsive manner. Such cells are then used to screen for compounds that modulate insulin promoter activity.Type: GrantFiled: September 14, 2006Date of Patent: March 22, 2011Assignee: The Burnham Institute for Medical ResearchInventors: Mark Mercola, Fred Levin, Pamela Itkin-Ansari
-
Patent number: 7906542Abstract: Crystalline polymorphous forms of rifaximin (INN), referred to as rifaximin ? and rifaximin ?, and a poorly crystalline form referred to as rifaximin ?, useful in the production of medicaments containing rifaximin for oral and topical use and obtained by means of a crystallization process carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a fixed temperature and for a fixed period of time, followed by a drying under controlled conditions until reaching a precise water content in the end product, are the object of the invention.Type: GrantFiled: May 13, 2008Date of Patent: March 15, 2011Assignee: Alfa Wassermann, S.p.A.Inventors: Giuseppe Claudio Viscomi, Manuela Campana, Dario Braga, Donatella Confortini, Vincenzo Cannata, Paolo Righi, Goffredo Rosini
-
Patent number: 7906132Abstract: The present invention relates to a method for the preparation of a biocompatible metal ion-containing titanium oxide coating on an implant wherein the metal ions can be eluted under physiological conditions and are homogeneously dispersed within the coating, as well as to an implant which can be prepared according to the method of the present invention.Type: GrantFiled: September 17, 2003Date of Patent: March 15, 2011Assignee: Biocer-Entwickslung GmbHInventors: Gunter Ziegler, Hans Gollwitzer, Frank Heidenau, Wolfram Mittelmeier, Frauke Stenzel
-
Patent number: 7902206Abstract: Crystalline polymorphous forms of rifaximin (INN) antibiotic named rifaximin ? and rifaximin ?, and a poorly crystalline form named rifaximin ?, useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying carried out under controlled conditions until reaching a settled water content in the end product, are the object of the invention.Type: GrantFiled: May 13, 2008Date of Patent: March 8, 2011Assignee: Alfa Wassermann, S.p.A.Inventors: Giuseppe Claudio Viscomi, Manuela Campana, Dario Braga, Donatella Confortini, Vincenzo Cannata, Paolo Righi, Goffredo Rosini
-
Patent number: 7897684Abstract: The invention further relates to polycationic multichromophores, which may be conjugated polymers, and methods, articles and compositions employing them as described herein. In some aspects, the invention relates to methods, articles and compositions for the detection and analysis of biomolecules in a sample. Provided assays include those determining the presence of a target biomolecule in a sample or its relative amount, or the assays may be quantitative or semi-quantitative. The methods can be performed on a substrate. The methods can be performed in an array format on a substrate, which can be a sensor. In some embodiments, detection assays are provided employing sensor biomolecules that do not comprise a fluorophore that can exchange energy with the cationic multichromophore.Type: GrantFiled: January 10, 2006Date of Patent: March 1, 2011Assignee: The Regents of the University of CaliforniaInventors: Guillermo C. Bazan, Bin Liu
-
Patent number: 7887782Abstract: The invention relates to novel radiotherapeutic formulations containing 224Ra and methods for their production. The invention discloses, in particular, radiotherapeutic formulations comprising at least one salt of the isotope 224Ra, which are characterized in that the content of other radionuclides, in particular, the respective content of certain longeval radionuclides does not exceed a specific numerical value in mBq/g. The invention also relates to a method for producing radiotherapeutic formulations of this type, which is characterized by the following steps: after at least one centrifugation of an aqueous suspension of the compound 228Th(OH)4 and optionally after the resuspension of the raw sediment obtained in said centrifugation, the precipitated 228Th(OH)4 sediment is separated. The supernatant solution of a 224Ra salt that has been obtained is subsequently subjected to sterile filtration and is then made up to the required dose.Type: GrantFiled: August 7, 2001Date of Patent: February 15, 2011Assignee: Altmann Therapie GmbH & Co.Inventors: Uwe Schwarz, Rolf Daniels
-
Patent number: 7866082Abstract: A long range, high intensity spotlight for human incapacitation and control that uses an incoherent collimated constant light source of sufficient intensity and focus to cause temporary incapacitation of a person for a period of time when illuminated by the beam without causing permanent physical harm. The high intensity spotlight comprises a head portion at one end having a window opening and a handle portion connected to the head portion and containing electronic circuitry and thermal air management for controlling operating temperature of the lamp. A paraboloid reflector is mounted in the head portion to face the window opening, and a high intensity electric arc Xenon lamp is adjustably mounted within the reflector so that the electrode gap is located as close as possible to the focus of the reflector. An adjustable mounting base allows the position of the reflector to be adjusted until the optimum focus is reached. A properly positioned cathode wire feed optimizes the lamp performance.Type: GrantFiled: February 5, 2009Date of Patent: January 11, 2011Assignee: Genesis Illumination, Inc.Inventors: Todd Eisenberg, Herbert Parker
-
Patent number: 7825265Abstract: Disclosed herein are novel di-aromatic compounds and methods for using various di-aromatic compounds for treatment and prevention of diseases and disorders related to estrogen receptors.Type: GrantFiled: November 8, 2005Date of Patent: November 2, 2010Assignee: ACADIA Pharmaceuticals Inc.Inventors: Roger Olsson, Lene Hyldtoft, Fabrice Piu, Magnus Gustafsson, Vladimir Sherbukhin, Birgitte Winther Lund
-
Patent number: 7811755Abstract: The invention relates to methods, articles and compositions for the detection and analysis of biomolecules in a sample. Provided assays include those determining the presence of a target biomolecule in a sample or its relative amount, or the assays may be quantitative or semi-quantitative. The methods can be performed in an array format on a substrate.Type: GrantFiled: January 10, 2006Date of Patent: October 12, 2010Assignee: The Regents of the University of CaliforniaInventors: Guillermo C. Bazan, Bin Liu
-
Patent number: 7781472Abstract: Disclosed herein are pharmaceutical compositions comprising oxybutynin, or a free base thereof or a pharmaceutically acceptable salt thereof, and pilocarpine, or a free base thereof or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.Type: GrantFiled: February 22, 2010Date of Patent: August 24, 2010Assignee: TheraVida, Inc.Inventor: Mehdi Paborji
-
Patent number: 7780165Abstract: The present invention provides a gaming apparatus adapted for substantially continuous play, comprising a first set of elements divisible into two or more distinguishable subsets; a second set of destinations divisible into two or more distinguishable subsets; selection means for selecting at random one element from the first set; association means for associating the randomly selected one element at random with one destination of the second set; and return means for returning the randomly selected one element to the start position. The present invention further provides adapting the above apparatus to an electronic gaming format.Type: GrantFiled: May 12, 2006Date of Patent: August 24, 2010Inventor: William Owen Cudlipp
-
Patent number: 7776914Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.Type: GrantFiled: June 16, 2009Date of Patent: August 17, 2010Assignee: Imagenetix, Inc.Inventors: William P. Spencer, Patrick S. Millsap
-
Patent number: 7759301Abstract: Surfactant-containing compositions are described which include a protein component that has the effect of improving the surface-active properties of the surfactants contained in the compositions. The surfactant-containing compositions having the protein component demonstrate significantly lower critical micelle concentrations (CMC) than do comparable compositions having no protein component. In addition, the surfactant-containing compositions having the protein component has the effect of converting greasy waste contaminants to surface active materials.Type: GrantFiled: February 9, 2010Date of Patent: July 20, 2010Assignee: Advanced BioCatalytics Corp.Inventors: John W. Baldridge, Carl W. Podella
-
Patent number: 7691832Abstract: Inflammatory bowel diseases are represented by two idiopathic disorders, which include ulcerative colitis and Crohn's disease. Ulcerative colitis is restricted to the colon and involves uncertain and inflammation of the lining (mucosa) of the large intestine. Crohn's disease, on the other hand, can involve the mucosa of the small and/or large intestine and may involve deeper layers of the bowel wall. The present invention contains N-acetylcysteine disposed in a pharmaceutically acceptable carrier for oral or rectal delivery for treating such inflammatory bowel diseases by topical application within the colon.Type: GrantFiled: February 2, 2006Date of Patent: April 6, 2010Assignee: The Board of Regents of the University of OklahomaInventor: Richard F. Harty
-
Patent number: D624711Type: GrantFiled: December 19, 2008Date of Patent: September 28, 2010Assignee: Canine GeniusInventors: Alise Shatoff, Birte M. Haakansson
-
Patent number: D631108Type: GrantFiled: March 17, 2010Date of Patent: January 18, 2011Assignee: Fitness Brands 2 LLCInventors: David Brodess, Michael Casey